| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BRD-K92856060 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | Epothilone B | GDSC1000 | pan-cancer | AAC | 0.025 | 0.5 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | TG-101348 | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | Erlotinib | gCSI | pan-cancer | AAC | 0.037 | 0.5 |
| mRNA | phloretin | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.023 | 0.5 |
| mRNA | Cytarabine | FIMM | pan-cancer | AAC | 0.11 | 0.5 |
| mRNA | PF-750 | CTRPv2 | pan-cancer | AAC | -0.026 | 0.5 |
| mRNA | BRD-K17060750 | CTRPv2 | pan-cancer | AAC | 0.025 | 0.5 |